Name the outcome before comparing claims
Conceptual comparison, not personal readings, a diagnostic chart or a testing schedule.
| Outcome | What it describes | What it cannot establish alone |
|---|---|---|
| Glucose reading | Glucose at a particular measurement time | Your longer-term pattern or why that reading changed |
| HbA1c | An indicator of average glucose exposure over about three months | Every day's highs and lows or a quitting-only effect |
| New type 2 diabetes diagnosis in a cohort | New diagnoses during follow-up in the specified population | Your glucose trajectory, diagnosis or personal probability |
Two results can point in different directions without contradicting each other
Imagine a fictional reader who has recently quit: one glucose reading is lower, but a later HbA1c result has not fallen. These are not equivalent observations. Meals, activity, illness and stress can affect glucose; HbA1c reflects a longer period, including time before a recent quit date. Recent weeks have more influence than earlier weeks, but it is not a simple average of three equally weighted calendar months. Neither result on its own establishes what quitting caused.
NIDDK explains that red-blood-cell and haemoglobin changes can also affect HbA1c, and that discordant results need professional interpretation. This is not an invitation to diagnose an interference yourself or dismiss an unwelcome result. The table separates questions, not normal and abnormal values.
CDC notes that glucose may fall after quitting and encourages discussion of nicotine-containing cessation support with a doctor when diabetes is present. That possibility is not a promise of lower HbA1c, a reason to change a glucose-lowering medicine yourself, or evidence that every nicotine exposure ends when cigarettes stop.
Existing diabetes and newly diagnosed diabetes are different study populations
The public abstract of Lycett's 2015 UK study reports an observational analysis of primary-care records from 2005–2010 in adults who already had type 2 diabetes. It found a higher average HbA1c during the first year after cessation, with the association diminishing over longer abstinence. It did not say every quitter's glucose rises, and its model did not attribute that HbA1c association to weight change. This is a different question from whether someone without diabetes later receives a diagnosis; the abstract does not establish a personal duration or treatment plan.
Hu's 2018 study instead followed three US cohorts and identified new physician-diagnosed type 2 diabetes, confirmed through an additional questionnaire. Compared with continuing smokers, people classified as having quit for two to six years had higher incidence, especially with greater weight gain. The estimate for those without weight gain was uncertain and did not show a clear increase; it did not prove zero risk. No series of each person's glucose or HbA1c after their quit date was measured by this outcome.
These were observational comparisons, not random assignment to quit or continue. Smoking and weight were self-reported at two-year intervals, quit dates were estimated, and remaining confounding is possible. Participants were mainly white health professionals; the diabetes analysis excluded major baseline disease. A modelled group association cannot identify the cause of your laboratory change or supply a universal risk deadline.
Do not turn a risk headline into a decision to postpone quitting
In Hu's study, cardiovascular and all-cause mortality were lower among quitters than continuing smokers across weight-change groups, despite the diabetes-incidence association. Mortality and new diabetes are separate outcomes: one does not cancel the other or calculate your personal balance of risks. Smoking itself raises type 2 diabetes risk and complicates existing diabetes. A concerning measurement deserves assessment, not an assumption that smoking protects you.
Take questions about glucose results, symptoms, HbA1c interpretation and treatment to the clinician responsible for your care; the monitoring and medication plan belongs there, not in a quitting timeline. In England, NHS local stop-smoking services offer separate support; confirm access and use local services elsewhere. This page does not receive glucose readings, prescriptions, weight or quit dates, set thresholds or specify meals, tests or drug changes.
What to keep in mind
Sources
The central claims on this page were checked against the sources below.
- National Institute of Diabetes and Digestive and Kidney Diseases: A1C and glucose: measurement windows, variation and clinical interpretation
Sources checked: 2026-10-06
- Centers for Disease Control and Prevention: Diabetes and smoking: possible glucose changes and professional support
Sources checked: 2026-10-06
- The Lancet Diabetes & Endocrinology / PubMed: Lycett et al. (2015): public abstract of UK cohort on HbA1c in existing type 2 diabetes
Sources checked: 2026-10-06
- New England Journal of Medicine: Hu et al. (2018): cessation, weight change, incident type 2 diabetes and mortality
Sources checked: 2026-10-06
- NHS: England: local stop-smoking support
Sources checked: 2026-10-06
General evidence interpretation, not a glucose forecast, diagnostic threshold, testing schedule, dietary prescription or medication adjustment.